Catalyst Pharmaceuticals
CPRX
#3685
Rank
A$5.43 B
Marketcap
A$44.39
Share price
-0.06%
Change (1 day)
21.51%
Change (1 year)

Market capitalization of Catalyst Pharmaceuticals (CPRX)

Market cap: A$5.43 Billion

As of June 2026 Catalyst Pharmaceuticals has a market cap of A$5.43 Billion. This makes Catalyst Pharmaceuticals the world's 3685th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Catalyst Pharmaceuticals from 2006 to 2026

End of year Market Cap

Year Marketcap Change
2026A$5.43 B21.56%
2025A$4.46 B8.53%
2024A$4.11 B56.51%
2023A$2.63 B-7.53%
2022A$2.84 B195.76%
2021A$0.96 B113.35%
2020A$0.45 B-18.6%
2019A$0.55 B97.78%
2018A$0.28 B-45.44%
2017A$0.51 B325.02%
2016A$0.12 B-56.66%
2015A$0.27 B11.08%
2014A$0.25 B111.96%
2013A$0.11 B582.55%
2012A$17.33 M-44.21%
2011A$31.07 M64.41%
2010A$18.9 M49.42%
2009A$12.65 M-64.73%
2008A$35.87 M-27.44%
2007A$49.43 M-35.54%
2006A$76.69 M

End of Day market cap according to different sources

On Jun 16th, 2026 the market cap of Catalyst Pharmaceuticals was reported to be:

A$5.43 Billion
by Nasdaq info icon info icon
A$5.43 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Johnson & Johnson
JNJ
A$801.52 B 14,655.85%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
A$210.12 B 3,768.32%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
A$223.47 B 4,014.09%๐Ÿ‡บ๐Ÿ‡ธ USA
Sarepta Therapeutics
SRPT
A$2.35 B-56.58%๐Ÿ‡บ๐Ÿ‡ธ USA
Acorda Therapeutics
ACOR
A$1.16 M-99.98%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
A$15.08 B 177.69%๐Ÿ‡บ๐Ÿ‡ธ USA